Limoges university hospital
Limoges, 87042, France
NCT Number: NCT05477238
Stroke is major public health issue. The investigators recommend post-stroke patients to practice physical activity. Nevertheless, the recommendations are not widely respected due to the intensity of exercises. Oxygen consumption is a parameter to assess the intensity of physical activity. in this sense, we want to measure the oxygen consumption during various walking tasks compared to healthy controls.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Limoges, 87042, France
Stroke is defined as an interruption of blood circulation in the brain. The treatments are in first time medical in emergency. Then, the patient will start his rehabilitation with several contributors. At this time, it will recommend physical activity to patients. Regardless of the all benefits of physical activity, it will help patient to avoid a second stroke. The investigators have the recommendations of the high authority of health in physical activity for stroke population. It recommends to practice around 20 to 60 minutes daily of physical activity with moderate effort intensity. Oxygen consumption is a parameter of effort intensity of physical activity measured in ml O2/kg/min. Currently, the investigators have the compendium of physical activity (PA). it allows us to classify PA according to effort intensity. And so, an activity with a moderate effort intensity is an activity between 3 and 5.9 metabolic equivalent task (MET). Note that 1 MET is 3.5 ml/O2/Kg. Nevertheless, this compendium does not correspond to post-stroke individuals. As consequences, Low intensity exercise as described in guidelines might be at a moderate intensity level for stroke survivors. Hence, the investigators want to assess the oxygen consumption of post-stroke individuals during various walking tasks and compare it to healthy controls.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Common to both groups:
Specific to the cerebrovascular accident Group:
Healthy Group Specific:
Exclusion criteria
Cerebrovascular accident group - Severe cognitive impairment (MoCA < 18)
Common to both groups:
The experiment will be divided in two sessions. In the first session, the participant/healthy volunteers will do 3 walking tasks (over ground walking/ climbing up, down stairs). In the second session, the participant will walk outside in front of the hospital (walking on a slope, walking down, walking on uneven ground). All those tasks will be done while wearing a gas exchange analyzer, accelerometer and a heart rate meter.
Time frame: Day 1
Oxygen consumption by indirect calorimetry (respiratory gas exchange analyzer: Metamax) expressed in mL.min-1.kg-1
Time frame: Day 7
Oxygen consumption by indirect calorimetry (respiratory gas exchange analyzer: Metamax) expressed in mL.min-1.kg-1
Time frame: Day 1
Average walking speed measured (distance walked/total time) during different travel activities
Time frame: Day 7
Average walking speed measured (distance walked/total time) during different travel activities
Time frame: Day 1
Average heart rate during activity measured by heart rate meter in bpm
Time frame: Day 7
Average heart rate during activity measured by heart rate meter in bpm
Time frame: Day 1
Perception of effort by the Borg scale during the last minute of the movement activity
Time frame: Day 7
Perception of effort by the Borg scale during the last minute of the movement activity
Time frame: Day 1
Total energy expenditure during each movement activity estimated by an Actigraph GT3X placed at the healthy ankle
Time frame: Day 7
Total energy expenditure during each movement activity estimated by an Actigraph GT3X placed at the healthy ankle
University Hospital, Limoges
Other
Acronym: STROXCO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03448159
Behavior, Brain Diseases
Calgary, Alberta, Canada
View Trial DetailsNCT01864382
Behavior, Brain Diseases
Barcelona, Catalonia, Spain
View Trial DetailsNCT01915368
Behavior, Brain Diseases
Calgary, Alberta, Canada
View Trial DetailsNCT02703805
Behavior, Brain Diseases
Brantford, Ontario, Canada
View Trial Details